AP Pharma Inc /DE/

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AP Pharma Inc /DE/
TickerHRTX
CIK #0000818033
CUSIP427746102
SectorLife Sciences - Pharmaceutical Preparations
Address123 Saginaw Drive, Redwood City, CA 94063
Source [EDGAR]
CIK Filing 2011 - 2025
[0000818033] 10-K
[0000818033] 10-Q
[0000818033] 3
[0000818033] 4
[0000818033] 5
[0000818033] 8-K
[0000818033] D
[0000818033] SC 13D
[0000818033] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Management LP Heron Therapeutics Inc /DE/ [2024-11-12] 5.84
BlackRock Inc Heron Therapeutics Inc /DE/ [2024-11-08] 5.6
BlackRock Inc Heron Therapeutics Inc /DE/ [2024-10-24] 5.6
Great Point Partners LLC Heron Therapeutics Inc /DE/ [2023-04-13] 5.35
Rubric Capital Management LP Heron Therapeutics Inc /DE/ [2023-02-06] 0.9
Deep Track Capital LP Heron Therapeutics Inc /DE/ [2022-08-19] 0.99
UBS OConnor LLC Heron Therapeutics Inc /DE/ [2022-02-14] 8.12
State Street Corp Heron Therapeutics Inc /DE/ [2022-02-11] 7.55
JPMorgan Chase & Co Heron Therapeutics Inc /DE/ [2022-01-24] 6.1
ArrowMark Colorado Holdings LLC Heron Therapeutics Inc /DE/ [2021-02-16] 5.9
Tang Capital Partners LP Heron Therapeutics Inc /DE/ [2020-11-19] 9.86
Wellington Management Group LLP Heron Therapeutics Inc /DE/ [2019-02-12] 5.87
Vanguard Group Inc Heron Therapeutics Inc /DE/ [2019-02-11] 8.09
BlackRock Inc Heron Therapeutics Inc /DE/ [2019-02-08] 6.3
Janus Henderson Group PLC Heron Therapeutics Inc /DE/ [2017-06-12] 10.5
Kingdon Capital Management LLC Heron Therapeutics Inc /DE/ [2017-02-14] 0.82
BlackRock Inc Heron Therapeutics Inc /DE/ [2017-01-30] 5.5
Janus Capital Management LLC Heron Therapeutics Inc /DE/ [2016-02-16] 8.7
Invesco Ltd Heron Therapeutics Inc /DE/ [2016-02-10] 0.2
FMR LLC Heron Therapeutics Inc /DE/ [2015-10-09] 0.0
Cormorant Global Healthcare Master Fund LP Heron Therapeutics Inc /DE/ [2015-08-28] 5.6
Partner Fund Management LP Heron Therapeutics Inc /DE/ [2015-07-09] 5.6
Kingdon Capital Management LLC Heron Therapeutics Inc /DE/ [2015-06-08] 0.56
SPCH LLLP AP Pharma Inc /DE/ [2013-04-09] 0.0
Savitr Capital LLC AP Pharma Inc /DE/ [2013-02-15] 11.8
FMR LLC AP Pharma Inc /DE/ [2013-02-14] 0.0
Baker Bros Advisors LLC AP Pharma Inc /DE/ [2013-02-01] 9.9
Broadfin Capital LLC AP Pharma Inc /DE/ [2012-12-31] 5.14
SPCH LLLP AP Pharma Inc /DE/ [2012-09-27] 11.8
Hambrecht & Quist Capital Management LLC AP Pharma Inc /DE/ [2012-02-14] 0.7
Form 3/4/5 Filer 2011 - 2025
Rubric Capital Management LP
Rosen David Efraim
Heron Therapeutics Inc /DE/
Morgan Adam
Collard Craig A
Forbes William P
Duarte Ira
Hensley Mark Earl
Christian Waage
Kaseta Michael
Dissanaike Sharmila
Johnson Craig A
Rodriguez Susan
Peraza Lisa
Szekeres David Leslie
Manhard Kimberly
Poyhonen John
Kotler Kevin
Velan Capital Investment Management LP
Velan Capital Management LLC
Velan Capital Master Fund LP
Velan Capital Holdings LLC
Venkataraman Balaji
Quart Barry D
Davis Stephen
Tang Kevin
Hoffman Robert E.
Rosen Robert
Tang Capital Management LLC
Tang Capital Partners LP
Drazba Brian G.
Marshall Paul
Clendeninn Neil James
Midler Andrew R
SPCH LLC
Savitr Capital, LLC
Gelder Mark S. MD
Whelan John
Adam Michael A
Turnbull Greg
Goddard Paul
Form 13F Holdings
Firm Period DFND Voting Shares
Rubric Capital Management LP [2025-06-30] SOLE 26,713,503 26,713,503
BlackRock, Inc. [2025-06-30] SOLE 9,835,767 10,101,715
Vanguard Group Inc [2025-06-30] SOLE 0 8,339,503
Adage Capital Partners GP LLC [2025-06-30] SOLE 7,852,000 7,852,000
Velan Capital Investment Management LP [2025-06-30] SOLE 6,986,744 6,986,744
Palisade Capital Management LP [2025-06-30] SOLE 3,096,481 5,086,903
Tejara Capital Ltd [2025-06-30] SOLE 4,517,415 4,517,415
Geode Capital Management LLC [2025-06-30] DFND 3,566,813 3,566,813
State Street Corp [2025-06-30] DFND 2,846,173 3,462,266
D. E. Shaw & Co., Inc. [2025-06-30] DFND 3,189,844 3,200,299
UBS Group AG [2025-06-30] DFND 3,175,066 3,184,965
Marshall Wace LLP [2025-06-30] OTR 0 2,894,072
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 2,805,039 2,805,039
Morgan Stanley [2025-06-30] DFND 2,696,062 2,761,591
Renaissance Technologies LLC [2025-06-30] SOLE 2,689,339 2,689,339
JW Asset Management LLC [2025-06-30] SOLE 2,337,743 2,337,743
Congress Park Capital LLC [2025-06-30] SOLE 0 2,268,249
Citadel Advisors LLC [2025-06-30] DFND 2,262,837 2,262,837
AIGH Capital Management LLC [2025-06-30] SOLE 2,218,123 2,218,123
Tang Capital Management LLC [2025-06-30] OTR 0 2,135,459
New York State Common Retirement Fund [2025-06-30] SOLE 1,760,045 1,760,045
Caption Management LLC [2025-06-30] SOLE 1,505,900 1,505,900
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,186,120 1,186,120
Northern Trust Corp [2025-06-30] DFND 1,128,747 1,129,230
Monaco Asset Management SAM [2025-06-30] SOLE 1,080,000 1,080,000
Bank of America Corp /DE/ [2025-06-30] DFND 16,197 1,075,269
Goldman Sachs Group Inc [2025-06-30] DFND 1,016,459 1,023,918
JPMorgan Chase & Co [2025-06-30] DFND 878,919 953,080
Two Sigma Investments LP [2025-06-30] SOLE 940,582 940,582
Clearline Capital LP [2025-06-30] SOLE 857,166 857,166
Prev | Page 9 | Next
Terms | Privacy | Guide
tony@aum13f.com